Cargando…
Melatonin ameliorates bleomycin-induced pulmonary fibrosis via activating NRF2 and inhibiting galectin-3 expression
Pulmonary fibrosis (PF) is a chronic interstitial lung disease with no effective therapies. Galectin-3 (Gal-3), a marker of oxidative stress, plays a key role in the pathogenesis of PF. Fibroblast-myofibroblast differentiation (FMD) is an important source of fibrotic cells in PF. Previous studies sh...
Autores principales: | Lan, Yue-jiao, Cheng, Ming-han, Ji, Hui-min, Bi, Yu-qian, Han, Yong-yue, Yang, Chong-yang, Gu, Xuan, Gao, Jian, Dong, Hong-liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638373/ https://www.ncbi.nlm.nih.gov/pubmed/36333557 http://dx.doi.org/10.1038/s41401-022-01018-x |
Ejemplares similares
-
Mefunidone Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Mice
por: Han, Yuanyuan, et al.
Publicado: (2021) -
Imrecoxib attenuates bleomycin-induced pulmonary fibrosis in mice
por: Miao, Yang, et al.
Publicado: (2023) -
Hyperbaric Oxygen Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Mice
por: Yuan, Yuan, et al.
Publicado: (2021) -
Antiflammin-1 attenuates bleomycin-induced pulmonary fibrosis in mice
por: Liu, Wei, et al.
Publicado: (2013) -
Distal airway stem cells ameliorate bleomycin-induced pulmonary fibrosis in mice
por: Shi, Yun, et al.
Publicado: (2019)